ACE and diabetes mellitus: This aspect is crucial because, while it is ascertained that ACE2 is the most recognized door for the entry, on the other side to target only ACE2 could be limiting considering that recent data show that ACE2 is up-regulated in diabetes and treatment with ACE inhibitors and angiotensin II type-I receptor blockers (Fang et al., 2020).